New Threads Only:  Add to Google Reader or Homepage
New Threads & Replies:  Add to Google Reader or Homepage
Forums are for serious investors only. GuruFocus Forum Rules.

Forum List » Business News and Headlines
SEC Filings, Earing Reports, Press Releases
New Topic Search
Goto Thread: PreviousNext
Goto: Forum ListMessage ListNew TopicSearchLog In
Ligand Pharmaceuticals Inc. (LGND) CEO John L Higgins buys 1,000 Shares
Posted by: gurufocus (IP Logged)
Date: May 8, 2012 01:28PM

President & CEO of Ligand Pharmaceuticals Inc. (LGND) John L Higgins buys 1,000 shares of LGND on 05/04/2012 at an average price of $12.04 a share.

Ligand Pharma-b has a market cap of $274 million; its shares were traded at around $12.23 with and P/S ratio of 9.1.

Directors and Officers Recent Trades:


  • 10% Owner Partners L P/il Bvf bought 511,040 shares of LGND stock on 11/21/2011 at the average price of 10.65. Partners L P/il Bvf owns at least 2,793,362 shares after this. The price of the stock has increased by 14.84% since.
  • Director Stephen L Sabba bought 2,000 shares of LGND stock on 11/14/2011 at the average price of 11.6. Stephen L Sabba owns at least 12,704 shares after this. The price of the stock has increased by 5.43% since.
  • VP, Gen. Counsel & Secretary Charles S Berkman sold 3,606 shares of LGND stock on 03/08/2012 at the average price of 15.76. Charles S Berkman owns at least 17,328 shares after this. The price of the stock has decreased by 22.4% since.


For the complete insider trading history of LGND, click here.


Stocks Discussed: LGND,
Rate this post:




Sorry, only registered users may post in this forum.

Please Login if you have an account or Create a Free Account if you don't




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial